标题
Targeting cancer testis antigens in synovial sarcoma
作者
关键词
-
出版物
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 6, Pages e002072
出版商
BMJ
发表日期
2021-06-04
DOI
10.1136/jitc-2020-002072
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors
- (2020) Mikiya Ishihara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- Phase I dose escalation and expansion trial to assess the safety and efficacy of ADP-A2M4 SPEAR T cells in advanced solid tumors.
- (2020) David S. Hong et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States
- (2020) Seth M. Pollack et al. Cancer Medicine
- Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy
- (2020) Brett A Schroeder et al. Journal for ImmunoTherapy of Cancer
- Tumor mutation burden and checkpoint immunotherapy markers in primary and metastatic synovial sarcoma
- (2020) Mai He et al. HUMAN PATHOLOGY
- Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity
- (2020) Won Suk Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1
- (2019) Neeta Somaiah et al. CLINICAL CANCER RESEARCH
- Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
- (2019) Shihong Zhang et al. Cancer Immunology Research
- 1670OADP-A2M4 (MAGE-A4) in patients with synovial sarcoma
- (2019) B A Van Tine et al. ANNALS OF ONCOLOGY
- 1309TiPTrial in progress: First-in-human study of a novel anti-NY-ESO-1–anti-CD3, TCR-based bispecific (IMCnyeso) as monotherapy in NY-ESO-1/LAGE-1A-positive advanced solid tumours (IMCnyeso-101)
- (2019) J Lopez et al. ANNALS OF ONCOLOGY
- 1182PDA novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer exhibited early-onset cytokine release syndrome and subsequent tumour responses in synovial sarcoma patients
- (2019) H Hattori et al. ANNALS OF ONCOLOGY
- 1183PDAdoptive T cell therapy with TBI-1301 results in gene-engineered T cell persistence and anti-tumour responses in patients with NY-ESO-1 expressing solid tumours
- (2019) M O Butler et al. ANNALS OF ONCOLOGY
- Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
- (2019) Anna Pavlick et al. Cancer Immunology Research
- Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy
- (2019) Joseph P Sanderson et al. OncoImmunology
- Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
- (2019) Indu Ramachandran et al. Journal for ImmunoTherapy of Cancer
- Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor
- (2019) Jocelyn Joseph et al. Journal for ImmunoTherapy of Cancer
- The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma
- (2018) Matthew J. McBride et al. CANCER CELL
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Immune profiles of desmoplastic small round cell tumor and synovial sarcoma suggest different immunotherapeutic susceptibility upfront compared to relapse specimens
- (2018) Mary Frances Wedekind et al. PEDIATRIC BLOOD & CANCER
- Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259 T Cells in Synovial Sarcoma
- (2018) Sandra P. D'Angelo et al. Cancer Discovery
- Abstract 616: Interferon gamma induced transformation of the cold tumor microenvironment in patients with NY-ESO-1 expressing sarcomas
- (2018) Shihong Zhang et al. CANCER RESEARCH
- Prognostic impact of the tumor immune microenvironment in synovial sarcoma
- (2018) Naoki Oike et al. CANCER SCIENCE
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
- (2018) Christopher A. Vakulskas et al. NATURE MEDICINE
- PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy
- (2018) Sietse J Luk et al. OncoImmunology
- 1643PPazopanib in advanced or metastatic synovial sarcoma: The Gustave Roussy experience
- (2018) M Sroussi et al. ANNALS OF ONCOLOGY
- Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1
- (2017) Kunio Iura et al. HUMAN PATHOLOGY
- Paracrine osteoprotegerin and β-catenin stabilization support synovial sarcomagenesis in periosteal cells
- (2017) Jared J. Barrott et al. JOURNAL OF CLINICAL INVESTIGATION
- Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
- (2017) Hussein A Tawbi et al. LANCET ONCOLOGY
- Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8+ lymphocytes in primary sarcomas is subtype dependent
- (2017) Anke E.M. van Erp et al. Oncotarget
- Survival changes in Patients with Synovial Sarcoma, 1983-2012
- (2017) Shuncong Wang et al. Journal of Cancer
- Modeling synovial sarcoma metastasis in the mouse: PI3′-lipid signaling and inflammation
- (2016) Jared J. Barrott et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Adoptive T Cell Therapies: A Comparison of T Cell Receptors and Chimeric Antigen Receptors
- (2016) Daniel T. Harris et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial Sarcoma
- (2016) Theodore S. Nowicki et al. Cancer Immunology Research
- Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment
- (2015) Sandra P. D’Angelo et al. HUMAN PATHOLOGY
- Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study
- (2015) Akira Kawai et al. LANCET ONCOLOGY
- Comprehensive functional characterization of cancer–testis antigens defines obligate participation in multiple hallmarks of cancer
- (2015) Kimberly E. Maxfield et al. Nature Communications
- MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4
- (2015) Lynnette Marcar et al. PLoS One
- SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier
- (2015) Sakura Tamaki et al. PLoS One
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions
- (2014) Paul F. Robbins et al. JOURNAL OF IMMUNOLOGY
- NY-ESO-1 (CTAG1B) expression in mesenchymal tumors
- (2014) Makoto Endo et al. MODERN PATHOLOGY
- Oncogenic Functions of the Cancer-Testis Antigen SSX on the Proliferation, Survival, and Signaling Pathways of Cancer Cells
- (2014) Padraig D’Arcy et al. PLoS One
- Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8+ T cells
- (2014) Seth M Pollack et al. Journal for ImmunoTherapy of Cancer
- Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma
- (2013) Cigall Kadoch et al. CELL
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma
- (2012) Seth M. Pollack et al. CANCER
- Deconstruction of the SS18-SSX Fusion Oncoprotein Complex: Insights into Disease Etiology and Therapeutics
- (2012) Le Su et al. CANCER CELL
- SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the Japanese Musculoskeletal Oncology Group
- (2012) Satoshi Kawaguchi et al. CANCER SCIENCE
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis
- (2012) Jin-Ping Lai et al. MODERN PATHOLOGY
- SS18 Together with Animal-Specific Factors Defines Human BAF-Type SWI/SNF Complexes
- (2012) Evelien Middeljans et al. PLoS One
- A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma
- (2012) Lisa M. Ebert et al. PLoS One
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Mage-A Cancer/Testis Antigens Inhibit p53 Function by Blocking Its Interaction with Chromatin
- (2010) L. Marcar et al. CANCER RESEARCH
- MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases
- (2010) Jennifer M. Doyle et al. MOLECULAR CELL
- CT-X antigen expression in human breast cancer
- (2009) A. Grigoriadis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
- (2008) L. G. Almeida et al. NUCLEIC ACIDS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started